@article{JTD23649,
author = {Alfredo Addeo and Giuseppe Luigi Banna},
title = {The crucial role of predicting brain metastases development in non-small cell lung cancer patients},
journal = {Journal of Thoracic Disease},
volume = {10},
number = {Suppl 26},
year = {2018},
keywords = {},
abstract = {Over the past ten years we have witnessed many advances in the management of non-small cell lung cancer (NSCLC), with the 5-year over survival (OS) in the advanced disease that has shifted to approximately 15% both in NSCLC patients with epidermal growth factor receptor (EGFR) + NSCLC treated with tyrosine kinase inhibitors (TKIs) (1) and in those treated with immune-checkpoint inhibitors (ICPIs) (2) and up to approximately 50% in NSCLC patients with anaplastic lymphoma kinase (ALK)+ tumours following first-line crizotinib (3).},
issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/23649}
}